Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
World Health Advanced Technologies is a small U.S.-based healthcare company associated with the Enercel line of products marketed as homeopathic medications. Publicly available information ties the company to enercel.com and Sarasota, Florida, and indicates it commercialized products including Enercel AM, Enercel Forte, Enercel Max, Enercel Mist-Nasal, Enercel Mist Nebulizer, Enercel PM, Vanicel, Enercel Plus, and Enercel Plus IM. The company appears to operate in the alternative medicine / homeopathic products segment rather than as a conventional biotech or pharmaceutical developer with a disclosed R&D pipeline. FDA publicly issued a warning letter to the company in June 2020 stating that several marketed products were unapproved new drugs and highlighting safety concerns regarding injectable products. Based on the available evidence, World Health Advanced Technologies is health-related, commercial-stage, and product-marketing focused, but it does not appear to have a conventional clinical biotech pipeline or validated target-based drug development program.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on World Health Advanced Technologies.